Navigation Links
PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
Date:9/10/2009

OXFORD, England, September 10 /PRNewswire/ -- PharmaVentures announced today the appointment of Nikki Watkins as Head of the Product & Portfolio Strategy Practice of Corporate Advisory, leading a team of Senior Advisors and Analysts.

Fintan Walton, PhD, PharmaVentures' Chief Executive Officer says, "We are delighted to welcome Nikki to PharmaVentures. Our Corporate Advisory business is currently undergoing exciting developments, and extensive knowledge of portfolio assessment and strategy from GSK and PricewaterhouseCoopers will be a key contributor to our growth plans."

Tibor Papp, PhD, Head of Corporate Advisory Ltd, says, "Nikki brings substantial industry and advisory experience into PharmaVentures. She will take on a leadership role, further developing our practice in strategic analysis of products, companies and markets. With Nikki's experience, PharmaVentures further strengthens its leading position as shapers of the industry."

Nikki has an honours degree in Pharmacology from Cambridge University. Most recently, she was the Director of Portfolio Consolidation & Analysis, Global Product Strategy, R&D at GlaxoSmithKline (GSK).

Nikki brings additional industry experience to PharmaVentures from various previous roles in GSK R&D, commercial analysis, portfolio management and global internal audit. Prior to this, she qualified as a Chartered Accountant at PricewaterhouseCoopers.

Notes to Editors:

About PharmaVentures

A leading results driven organisation, PharmaVentures (http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company provides tailored corporate advisory services to the Life Science industry, with additional
'/>"/>

SOURCE PharmaVenture
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
2. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
3. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
4. Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
5. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
6. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
7. Brookstone Pharmaceuticals Appoints New Corporate Position
8. OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
9. ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicons Research and Diagnostic Products
10. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... of circulating tumor cells (CTCs) in a mouse model ... in several groups of CTCs, including significant differences from ... to generate metastases. In their study reported in ... investigators from the Massachusetts General Hospital (MGH) Cancer Center ... unexpected factors that may prove to be targets for ...
(Date:9/22/2014)... developed a unique nanoscale device that for the ... discovery could have major implications for creating faster ... communication. , The research paper by University of ... Li and his graduate student Huan Li has ... October issue of Nature Nanotechnology . , ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Lawrence ... President John DeGioia on Friday renewed their institutional ... an additional five years to expand the collaborative ... nonproliferation and global climate, energy and environmental sciences. ... an MOU originally signed in December 2009 and ...
(Date:9/22/2014)... Sept. 22, 2014 US demand to rise ... specialty biocides is forecast to rise 3.9 percent per ... demand is projected to increase 1.3 percent per year ... strong rebound in construction expenditures will support demand for ... markets, while growth in consumer spending and manufacturing output ...
Breaking Biology Technology:Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3Engineers show light can play seesaw at the nanoscale 2Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2US Biocides Market 2US Biocides Market 3
... and PHILADELPHIA, July 4 ,Shire Limited (LSE:SHP, NASDAQ: SHPGY), ... earnings on,Thursday 31 July 2008, Results press ... BST / 07:00 EDT Investor meeting and conference ... Investor & Analyst meeting and conference call:, Angus ...
... Research Group has,released results from aboratory testing ... at Oregon State University which,demonstrated the Eniva ... for human cells. This third party testing ... effort to further identify,mechanisms by which the ...
... Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today announced that ... its cash burn rate. As previously,announced, the Company ... acquisitions and mergers. In conjunction with this,process, the ... its VP,series of drugs, and has determined that ...
Cached Biology Technology:Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008 2Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2
(Date:9/23/2014)... DNA fragments called "jumping genes" that insert themselves into ... that phenomenon can result in age-related diseases such as ... report that the "jumping genes" in mice become active ... keeping them in check in order to take on ... in Nature Communications , Professor of Biology Vera ...
(Date:9/22/2014)... that after a long stay in the Intensive Care ... remain behind in patients, intestines. The team tested these ... when provoked by conditions that mimic the body,s stress ... mBio , the online open-access journal of the American ... treatment of ICU patients who can develop a life-threatening ...
(Date:9/22/2014)... September 23, 2014 A new American Cancer ... Nutrition Assistance Program (SNAP), previously known as the ... compared with income eligible non-participants. The authors say ... aimed at enhancing the dietary quality of SNAP ... low-income individuals and households with the resources to ...
Breaking Biology News(10 mins):A multi-function protein is key to stopping genomic parasites from 'jumping' 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3Federal food program puts food on the table, but dietary quality could be improved 2
... Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) ... genetics of ALS. Amyotrophic lateral sclerosis (ALS), also ... fatal neurological disease involving the degeneration and death of ... the most common neuromuscular diseases worldwide, affecting as roughly ...
... sturgeons, more caviar will be exported from Caspian Sea ... of unacceptably permissive new trade quotas announced Thursday by ... Most sturgeon species are endangered and some, like beluga ... damage this ancient fish,s chance of recovery and survival, ...
... New research* shows that while engineered nanomaterials can ... food chain from single celled organisms to higher ... and there was no evidence of the nanomaterials ... results observed by researchers from the National Institute ...
Cached Biology News:New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 2New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 3New CITES quotas allow more caviar export, further jeopardize endangered sturgeon 4Research measures movement of nanomaterials in simple model food chain 2
Request Info...
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
... 211 ] affinity isolated antibody aqueous solution ... (without Mg 2+ and Ca 2+ ), ... protease free) and 0.05% sodium azide. a synthetic ... Hck that contains tyrosine 207 and serine 209 ...
High voltage electrophoresis power supply...
Biology Products: